Cannabis and its dilemmas in psychiatry

Autores/as

  • Vinicius Broilo Facco
  • Fernando Gabriel Rodrigues
  • Giulia Maria Dal Castel
  • Larissa Ferreira Campos
  • Martina Estacia da Cas
  • Pedro Henrique Sarmento Dariz
  • Jefferson José Rodrigues Escobar

Palabras clave:

Cannabinoids, Cannabis, Psychiatry

Resumen

In the 1960s, the two main chemical structures in the Cannabis plant were isolated: delta-9-tetrahydrocannabinol (Δ9 -THC), a psychotropic component of the plant, and cannabidiol (CBD), a non-psychotropic substance with therapeutic potential. The possible use as a medicine is justified by the wide distribution of cannabinoid receptors in the body. There is still no consensus on the use of CBD in the treatment of psychiatric conditions, as the implementation of this new therapy has been controversial. The Brazilian Association of Psychiatry (ABP) was irremediably against its use, despite some studies reporting benefits.

 

DOI:https://doi.org/10.56238/alookdevelopv1-022

Descargas

Publicado

2023-05-08

Cómo citar

Facco, V. B., Rodrigues, F. G., Castel, G. M. D., Campos, L. F., Cas, M. E. da, Dariz, P. H. S., & Escobar, J. J. R. (2023). Cannabis and its dilemmas in psychiatry. Seven Editora. Recuperado a partir de https://sevenpublicacoes.com.br/editora/article/view/1258

Número

A LOOK AT DEVELOPMENT

Sección

Health Sciences

Licencia

Derechos de autor 2023 Vinicius Broilo Facco, Fernando Gabriel Rodrigues, Giulia Maria Dal Castel, Larissa Ferreira Campos, Martina Estacia da Cas, Pedro Henrique Sarmento Dariz, Jefferson José Rodrigues Escobar

Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.